SANDUPHQPharmaceuticals
Sandu Pharmaceuticals, Inc — Balance Sheet
₹30.52
-6.58%
Sandu Pharmaceuticals, Inc Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.97 Cr | 0.97 Cr | 0.97 Cr | 0.88 Cr | — |
| Share Issued | 0.97 Cr | 0.97 Cr | 0.97 Cr | 0.88 Cr | — |
| Total Debt | 0.48 Cr | 0.06 Cr | — | 0.00 | 0.02 Cr |
| Tangible Book Value | 41.99 Cr | 40.56 Cr | 39.19 Cr | 36.44 Cr | — |
| Invested Capital | 42.02 Cr | 40.59 Cr | 39.24 Cr | 36.47 Cr | — |
| Working Capital | 14.21 Cr | 11.66 Cr | 11.66 Cr | 11.77 Cr | — |
| Net Tangible Assets | 41.99 Cr | 40.56 Cr | 39.19 Cr | 36.44 Cr | — |
| Capital Lease Obligations | 0.48 Cr | 0.06 Cr | — | — | — |
| Common Stock Equity | 42.02 Cr | 40.59 Cr | 39.24 Cr | 36.47 Cr | — |
| Total Capitalization | 42.02 Cr | 40.59 Cr | 39.24 Cr | 36.47 Cr | — |
| Total Equity Gross Minority Interest | 42.02 Cr | 40.59 Cr | 39.24 Cr | 36.47 Cr | — |
| Stockholders Equity | 42.02 Cr | 40.59 Cr | 39.24 Cr | 36.47 Cr | — |
| Other Equity Interest | 32.36 Cr | 2000.00 | -1000.00 | 0.44 Cr | — |
| Capital Stock | 9.66 Cr | 9.66 Cr | 9.66 Cr | 8.81 Cr | — |
| Common Stock | 9.66 Cr | 9.66 Cr | 9.66 Cr | 8.81 Cr | — |
| Total Liabilities Net Minority Interest | 13.70 Cr | 11.82 Cr | 14.93 Cr | 12.81 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 1.62 Cr | 1.18 Cr | 1.04 Cr | 0.94 Cr | — |
| Non Current Deferred Taxes Liabilities | 1.20 Cr | 1.12 Cr | 1.04 Cr | 0.94 Cr | — |
| Long Term Debt And Capital Lease Obligation | 0.42 Cr | 0.06 Cr | — | — | — |
| Long Term Capital Lease Obligation | 0.42 Cr | 0.06 Cr | — | — | — |
| Current Liabilities | 12.09 Cr | 10.64 Cr | 13.88 Cr | 11.87 Cr | — |
| Other Current Liabilities | 1.91 Cr | 0.51 Cr | 0.73 Cr | 0.61 Cr | — |
| Current Debt And Capital Lease Obligation | 0.06 Cr | 30000.00 | — | 0.00 | 0.02 Cr |
| Current Capital Lease Obligation | 0.06 Cr | 30000.00 | — | — | — |
| Current Provisions | 5.38 Cr | 1.24 Cr | 1.29 Cr | 1.14 Cr | — |
| Payables | 4.49 Cr | 4.72 Cr | 8.68 Cr | 7.26 Cr | — |
| Accounts Payable | 4.49 Cr | 4.23 Cr | 8.44 Cr | 6.86 Cr | — |
| Total Assets | 55.72 Cr | 52.41 Cr | 54.17 Cr | 49.28 Cr | — |
| Total Non Current Assets | 29.42 Cr | 30.11 Cr | 28.62 Cr | 25.64 Cr | — |
| Other Non Current Assets | -1000.00 | -3000.00 | -11000.00 | -2000.00 | — |
| Investmentin Financial Assets | 11.27 Cr | 12.23 Cr | 11.56 Cr | 9.14 Cr | — |
| Available For Sale Securities | 11.27 Cr | 12.23 Cr | 11.56 Cr | 9.14 Cr | — |
| Goodwill And Other Intangible Assets | 0.02 Cr | 0.03 Cr | 0.05 Cr | 0.03 Cr | — |
| Other Intangible Assets | 0.02 Cr | 0.03 Cr | 0.05 Cr | 0.03 Cr | — |
| Net PPE | 18.12 Cr | 17.84 Cr | 16.99 Cr | 16.45 Cr | — |
| Gross PPE | 18.12 Cr | 28.99 Cr | 27.56 Cr | 26.52 Cr | — |
| Construction In Progress | 0.00 | 0.00 | 0.42 Cr | 0.48 Cr | — |
| Other Properties | 18.12 Cr | 11.31 Cr | 11.08 Cr | 10.98 Cr | — |
| Current Assets | 26.30 Cr | 22.30 Cr | 25.55 Cr | 23.65 Cr | — |
| Other Current Assets | 4.74 Cr | 1000.00 | 0.18 Cr | 0.39 Cr | — |
| Inventory | 14.15 Cr | 12.25 Cr | 14.33 Cr | 11.27 Cr | — |
| Accounts Receivable | 4.76 Cr | 4.87 Cr | 4.79 Cr | 3.99 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 2.65 Cr | 1.21 Cr | 2.30 Cr | 4.17 Cr | — |
| Other Short Term Investments | 1.35 Cr | 0.20 Cr | 0.02 Cr | 3.23 Cr | — |
| Cash And Cash Equivalents | 1.30 Cr | 1.00 Cr | 2.28 Cr | 0.94 Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Fixed Assets Revaluation Reserve | — | 8.70 Cr | 8.84 Cr | 8.98 Cr | 9.12 Cr |
| Retained Earnings | — | 8.58 Cr | 7.69 Cr | 6.68 Cr | 4.97 Cr |
| Additional Paid In Capital | — | 2.76 Cr | 2.76 Cr | 1.85 Cr | 0.90 Cr |
| Current Deferred Taxes Liabilities | — | 1.91 Cr | 1.32 Cr | 1.53 Cr | 0.83 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 1.83 Cr | 1.47 Cr | 1.18 Cr | 1.19 Cr |
| Other Payable | — | 0.34 Cr | 0.15 Cr | 0.37 Cr | 0.34 Cr |
| Dividends Payable | — | 0.15 Cr | 0.09 Cr | 0.04 Cr | 0.00 |
| Accumulated Depreciation | — | -11.14 Cr | -10.57 Cr | -10.08 Cr | -9.58 Cr |
| Machinery Furniture Equipment | — | 9.06 Cr | 7.48 Cr | 6.93 Cr | 6.58 Cr |
| Buildings And Improvements | — | 8.62 Cr | 8.58 Cr | 8.13 Cr | 8.13 Cr |
| Land And Improvements | — | 0.00 | 0.00 | — | 0.00 |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 3.81 Cr | 3.71 Cr | 3.69 Cr | 2.26 Cr |
| Finished Goods | — | 10.35 Cr | 11.65 Cr | 9.36 Cr | 9.18 Cr |
| Work In Process | — | 1.02 Cr | 1.36 Cr | 0.57 Cr | 0.29 Cr |
| Raw Materials | — | 0.88 Cr | 1.32 Cr | 1.34 Cr | 1.66 Cr |
| Other Receivables | — | 0.16 Cr | 0.24 Cr | 0.12 Cr | 0.14 Cr |
| Allowance For Doubtful Accounts Receivable | — | -0.08 Cr | -0.06 Cr | -0.06 Cr | -0.13 Cr |
| Gross Accounts Receivable | — | 4.95 Cr | 4.85 Cr | 4.05 Cr | 5.47 Cr |
| Cash Equivalents | — | 0.10 Cr | 1.31 Cr | 0.00 | 0.22 Cr |
| Cash Financial | — | 0.90 Cr | 0.96 Cr | 0.94 Cr | 4.31 Cr |
| Other Non Current Liabilities | — | — | 1000.00 | -1000.00 | -1000.00 |
| Defined Pension Benefit | — | — | 0.02 Cr | 0.01 Cr | — |
| Other Inventories | — | — | 2000.00 | — | — |
| Current Debt | — | — | — | 0.00 | 0.02 Cr |
| Held To Maturity Securities | — | — | — | 0.00 | 4000.00 |
| Non Current Prepaid Assets | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sandu Pharmaceuticals, Inc
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.